Felice Gragnano։ Turning Cardiovascular Risk Into Action
Felice Gragnano, Associate Professor and Cardiologist at Università Vanvitelli, shared a post on LinkedIn:
”Prevent sooner. Prevent again. Better prevention.
The data presented at ESC Congress 2026 focus on one of the most important challenges of cardiovascular prevention: recognizing the risk early and then being able to translate the evidence into interventions that are actually applied in clinical practice.
We discussed this in this interview for Cardio Info, starting from the REACT and STAREE studies and arriving at the topic of diagnostic and therapeutic inertia and the implementation gap.
REACT reminds us that atherosclerosis can begin long before its clinical manifestation and that estimating risk and measuring disease are not the same thing.
STAREE shows that, even in old age, cardiovascular risk remains modifiable: chronological age, alone, should not make us give up prevention.
But knowing the risk and having effective therapies is not enough. The real challenge is to transform the evidence into timely, intensive and continuous prevention, overcoming inertia and bridging the gap between guidelines and daily practice, as evidenced by the results of our study Quality Matters.
Because prevention is not a single prescriptive act, but a path:
Identify, followed by measurement, treatment, re-evaluation, intensification, and maintenance.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 17:27John Strouse: Building Standards for Whole-Person Sickle Cell Care Through Collaboration
-
Oct 17, 2026, 17:20Jean-Jacques Kiladjian: Exploring the Future of Polycythemia Vera Treatment at MPN Horizons 2026
-
Oct 17, 2026, 17:10Habib Bennaceur: Strengthening Collaboration in Haemophilia, Sickle Cell Disease and Thalassaemia in India
-
Oct 17, 2026, 16:58Danny Hsu: Building Connections at the AUSNBled Collaborative Dinner in Auckland
-
Oct 17, 2026, 16:48Kalyan Roy: Enhancing Patient Experience Through Learning and Collaboration
-
Oct 17, 2026, 16:43Wilfried Dinh: Antiplatelet Therapy in 2026: Duration is Becoming a Dynamic Decision
-
Oct 17, 2026, 16:37Ian Setchfield: Dr. Evans Presents on Safe Anticoagulation Prescribing at East Kent Hospitals
-
Oct 17, 2026, 16:33Lewis Thomas: Connecting Through Shared Experiences at ASCAT 2026
-
Oct 17, 2026, 16:29Nilesh Jethwa: Yasmin Adverse Event Reports Exceed 23,000 Over Two-Year Period